Docetaxel-Gemcitabine

docetaxel-gemcitabine · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Docetaxel-Gemcitabine, covering 2019-09-12 to 2019-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer [Phase 2]